These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 1426792)

  • 21. [Changes in exercise capacity and in induced ischemia with an oral dose of 5 isosorbide mononitrate in patients with stable angina pectoris].
    Martín Luengo C; Nieto Ballesteros F; Santos Rodríguez I; Diego Domínguez M; Fernández Esteban T; Avila Escribano C; Pavón Osuna P; Cascón Bueno M
    An Med Interna; 1990 Jan; 7(1):24-7. PubMed ID: 2103193
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of isosorbide-5-mononitrate versus nifedipine in preventing spontaneous and ergonovine-induced myocardial ischaemia. A double-blind, placebo-controlled study.
    Lombardi M; Morales MA; Michelassi C; Moscarelli E; Distante A; L'Abbate A
    Eur Heart J; 1993 Jun; 14(6):845-51. PubMed ID: 8325315
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-ischemic effects of first and second dose of 20 mg isosorbide dinitrate administered 5 hours apart: attenuation of effects despite rising plasma concentration.
    Lehmann G; Reiniger G; Wolf H; Beyerle A; Rudolph W
    Cardiovasc Drugs Ther; 1995 Apr; 9(2):339-45. PubMed ID: 7662601
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Anti-ischemic efficacy of sustained-release isosorbide-5-mononitrate: echocardiography during mental and physical stress].
    Keck M; Tretter R; Sauerbrey-Wullkopf N
    Z Kardiol; 2001 Oct; 90(10):766-73. PubMed ID: 11757473
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Isosorbide 5-mononitrate (delayed release) in stable effort angina].
    Almenar Bonet L; Miró Palau V; Gimeno Gascón JV; Algarra Vidal F
    Rev Esp Cardiol; 1992; 45(7):456-61. PubMed ID: 1439070
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-anginal and anti-ischemic efficacy of conventional and slow release formulations of isosorbide-5-mononitrate in angina pectoris.
    Thadani U
    Z Kardiol; 1985; 74 Suppl 4():21-4. PubMed ID: 4096067
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Development of nitrate tolerance in individual patients with stable angina pectoris in various phases of therapy with oral isosorbide dinitrate].
    Kośmicki M; Szwed H; Kowalik I; Sadowski Z
    Pol Merkur Lekarski; 2002 Jul; 13(73):52-5. PubMed ID: 12362508
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Stress echocardiography--a new test for evaluating the anti-ischemic effect of medication].
    Leischik R; Adamczewski O; Pötter S; Erbel R; Lösse B
    Z Kardiol; 1995 Aug; 84(8):621-32. PubMed ID: 7571769
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Comparison of the effectiveness of olicard 40 retard and cardonit 40 prolongatum preparations in treatment of stable coronary heart disease].
    Kurpesa M; Krzemińska-Pakuła M; Kedzia E; Trzos E; Musiał W; Peruga Z
    Wiad Lek; 1994 Aug; 47(15-16):587-90. PubMed ID: 7716955
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effects of slow-release isosorbide-5-mononitrate on ergometric parameters and cardiac output in stable effort angina pectoris: a double-blind randomized placebo study].
    Romeo F; Barillà F; Pelliccia F; Ferraironi A; Ciolli A; Pannarale G; Vicchio D; Valente A
    Cardiologia; 1989 Jul; 34(7):643-50. PubMed ID: 2676173
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The acute and chronic effects of 50 mg of isosorbide 5-mononitrate with delayed action in patients with stable angina of effort].
    San José Garagarza J; Ruano Calvo J; Vázquez de Prada JA; Colman Dejean T; López Somoza C; Pajarón López A
    Rev Esp Cardiol; 1992 Feb; 45(2):103-10. PubMed ID: 1561466
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical comparison of antiischemic efficacy of isosorbide dinitrate and molsidomine.
    Lehmann G; Reiniger G; Beyerle A; Schömig A
    J Cardiovasc Pharmacol; 1998 Jan; 31(1):25-30. PubMed ID: 9456273
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Randomized controlled trial of oral captopril, of oral isosorbide mononitrate and of intravenous magnesium sulphate started early in acute myocardial infarction: safety and haemodynamic effects. ISIS-4 (Fourth International Study of Infarct Survival) Pilot Study Investigators.
    Flather M; Pipilis A; Collins R; Budaj A; Hargreaves A; Kolettis T; Jacob A; Millane T; Fitzgerald L; Cedro K
    Eur Heart J; 1994 May; 15(5):608-19. PubMed ID: 8055999
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Coronary artery disease observed in general hospitals: ETTIC study. Comparison between trimetazidine and mononitrate isosorbide for patients receiving betablockers].
    Hanania G; Haïat R; Olive T; Maalouf B; Michel D; Martelet M; Godard S;
    Ann Cardiol Angeiol (Paris); 2002 Nov; 51(5):268-74. PubMed ID: 12515103
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Comparison of dinitrate isosorbide retard forms in ischemic heart disease patients with stable effort angina].
    Lupanov VP; Alekseeva IA; Vasil'eva NN; Komar OA; Romasiuk SS; Naumov VG
    Ter Arkh; 2000; 72(9):33-6. PubMed ID: 11076413
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Efficacy of mononitrate retard therapy in patients with advanced congestive heart failure].
    Chmielewski M; Mamcarz A; Dłuzniewski M; Braksator W; Król J; Krysztofiak H; Kuch M; Beranek G
    Pol Merkur Lekarski; 1997 Sep; 3(15):101-4. PubMed ID: 9461702
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical evaluation of the changes produced by nitrates in patients with chronic heart insufficiency].
    Almenar L; Gimeno JV; Sotillo J; Moreno MT; Salvador A; Miró V; Mora V; Martínez Dolz L; Algarra F
    Rev Esp Cardiol; 1993 May; 46(5):298-303. PubMed ID: 8516538
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reduction of exercise-induced myocardial perfusion defects by isosorbide-5-nitrate: assessment using quantitative Tc-99m-MIBI-SPECT.
    Göller V; Clausen M; Henze E; Giesler M; Schmidt A; Kochs M; Hombach V
    Coron Artery Dis; 1995 Mar; 6(3):245-9. PubMed ID: 7788038
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Echo-dipyridamole stress test evaluation of isosorbide-5-mononitrate efficacy and tolerance in patients with coronary heart disease: interplay with sympathetic activity.
    Longobardi G; Ferrara N; Leosco D; Abete P; Iannuzzi GL; Acanfora D; Furgi G; Nicolino A; Pinna G; Rengo F
    J Cardiovasc Pharmacol; 2000 Jul; 36(1):50-5. PubMed ID: 10892660
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effects of isosorbide-5-mononitrate on exercise capacity, prostacyclin synthesis, the renin-aldosterone axis and catecholamines in patients with cardiac insufficiency].
    Gandini R; Baggio E; Pozzoli G; Massari D; Megali R; Vargiu B; Maraffi F; Assereto R; Montella S
    Cardiologia; 1989 May; 34(5):447-53. PubMed ID: 2758447
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.